Latest Articles for Immunotherapy

Hydroporation enhances CAR-T cell therapy by improving T-cell viability and targeting effectiveness.

Research on neoantigen-based vaccines aims to improve immune response against cancer.

AI helps create new antibodies targeting PD-1 for better cancer therapies.

A study reveals potential benefits of anti-miR-155 for NSCLC patients.

Research reveals new insights on cancer spread and immune response in head and neck cancer.

UnifyImmun predicts antigen binding, enhancing cancer immunotherapy effectiveness.

New models show promise for combining oncolytic viruses and immune therapies in cancer.

Combining therapies shows promise for extending survival in glioblastoma patients.

New minibinders enhance synthetic receptor technology for improved disease detection.

Adenoid cystic carcinoma poses significant treatment challenges due to its unique characteristics.

New models optimize cancer therapy while addressing heart risks from treatments.

Exploring CT imaging's role in assessing immune response in lung cancer.

Research reveals potential of Zika virus in treating childhood brain cancer.

Research highlights a gut bacterium's potential to aid breast cancer therapies.

Investigating how TNFSF genes impact breast cancer treatment and patient outcomes.

Examining how tumor surroundings affect cancer treatment responses.

Research explores how metabolism affects the success of CAR-T cell therapy for cancer.

A device offers real-time tracking of cancer treatment responses, improving patient care.

Research uncovers potential for better HCC diagnosis and treatment strategies.

New treatments show promise for advanced colorectal cancer patients.

A study reveals DoriVac's potential in treating melanoma by enhancing immune response.

Research offers new hope for improving brain metastasis treatment responses in melanoma patients.

Hematoxylin and eosin staining enhances immune cell evaluation in tumors.

A new drug, NUC-3373, shows promise in improving immune response in colorectal cancer.

A promising new method enhances predictions for cancer treatment outcomes using immune checkpoint inhibitors.

Examining how the tumor microenvironment affects immune response in cancer.

New methods enhance T cell modifications for cancer treatment.

Research focuses on new therapies for aggressive brain tumors in pediatric patients.

New T cell methods aim to target tumors safely and effectively.

New insights into cervical cancer, particularly adenocarcinoma, offer hope for improved treatments.

Combining therapies could improve outcomes for gastric cancer patients.

New techniques enhance CAR T cell therapy effectiveness against cancer.

Study reveals immune profiles predicting treatment outcomes in relapsed EOC patients.

Research reveals complexities in treating biliary tract cancers and immune interactions.

Researchers develop new antigen-binding domains to improve CAR-T therapies against cancer.

New strategies using mini-binders show promise for targeting cancer cells effectively.

Genomic changes influence cancer growth and treatment responses.

New methods are enhancing CAR development through machine learning innovations.

Tarlatamab shows promise for patients with small cell lung cancer.

Research identifies potential markers for better predicting HNSCC treatment responses.